![Reto Crameri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Reto Crameri
Precedenti posizioni note di Reto Crameri
Società | Posizione | Inizio | Fine |
---|---|---|---|
ImVisioN GmbH
![]() ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services ImVisioN GmbH provides research in intralymphatic immunotherapy. It is a biotechnology company which specializes the use of intralymphatic immunotherapy to develop treatments for major allergies. Its product, IVN201, is a MAT immunotherapeutic that targets cat dander allergy, a common allergy inadequately addressed by available therapeutic interventions. The company was founded in 2005 and is headquartered in Hanover, Germany. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Reto Crameri
Swiss Federal Institute of Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 2 |
Svizzera | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
ImVisioN GmbH
![]() ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services ImVisioN GmbH provides research in intralymphatic immunotherapy. It is a biotechnology company which specializes the use of intralymphatic immunotherapy to develop treatments for major allergies. Its product, IVN201, is a MAT immunotherapeutic that targets cat dander allergy, a common allergy inadequately addressed by available therapeutic interventions. The company was founded in 2005 and is headquartered in Hanover, Germany. | Commercial Services |
- Borsa valori
- Insiders
- Reto Crameri
- Esperienza